Sphs stock premarket
Sophiris Bio Inc. (SPHS) Stock Message Board - InvestorsHub Sophiris Bio Inc. Sophiris Bio Inc. is a Canadian urology company with operations based in San Diego developing a late-stage, highly targeted treatment for benign prostatic hyperplasia (BPH or enlarged prostate), a large unsatisfied market. SPHS Sophiris Bio, Inc. Stock Quote - FINVIZ.com Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of products for the treatment of urological diseases.
Sophiris Bio (SPHS) Stock Quote | Price Chart | Volume Chart
Dec 17, 2018 · Sophiris Bio (NASDAQ:SPHS) -29% after providing updates on Phase 2b prostate cancer trial. Stock Ideas by Sector; Stock Ideas Editors Picks Healthcare stocks among premarket … SPHS - Sophiris Bio Summary, Stock Quote and News | Benzinga Jan 01, 2010 · Sophiris Bio (NASDAQ: SPHS) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. Sophiris Bio Inc., SPHS Quick Chart - (OTC) SPHS, Sophiris ... SPHS - Sophiris Bio Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Sophiris Bio's stock plummets 30% premarket after share offering prices at deep discount MarketWatch. 09:04 AM ET. Sophiris Bio prices share offering at $4 a share, 31% below Monday's closing price MarketWatch. Monday SPHS Institutional Ownership - Sophiris Bio, Inc. Stock
Sophiris Bio (NASDAQ:SPHS) Fda | Benzinga
SPHS - Sophiris Bio Inc., Stock Quote, Analysis, Rating ... Sophiris Bio Inc is a clinical-stage biopharmaceutical company. The Company is engaged in research and development of products for the treatment of urological diseases. It is currently developing PRX302 for treatment of benign prostatic hyperplasia. Stock Price Prediction: Update at 5:00pm EST SOPHIRIS BIO INC (SPHS) stock forum & discussion – Yahoo ... Find the latest SOPHIRIS BIO INC (SPHS) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. SPHS | Stock Snapshot - Fidelity Apr 01, 2020 · Stock quote and company snapshot for SOPHIRIS BIO INC (SPHS), including profile, stock chart, recent news and events, analyst opinions, and research reports. SPHS - Sophiris Bio Stock Price - Barchart.com
Sophiris Bio (SPHS) Stock Quote | Price Chart | Volume Chart
SPHS - Sophiris Bio Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Sophiris Bio's stock plummets 30% premarket after share offering prices at deep discount MarketWatch. 09:04 AM ET. Sophiris Bio prices share offering at $4 a share, 31% below Monday's closing price MarketWatch. Monday
Sophiris Bio PREMARKET, LIVE AND AFTER ... - Markets Insider
Sophiris Bio Inc. Sophiris Bio Inc. is a Canadian urology company with operations based in San Diego developing a late-stage, highly targeted treatment for benign prostatic hyperplasia (BPH or enlarged prostate), a large unsatisfied market. SPHS Sophiris Bio, Inc. Stock Quote - FINVIZ.com Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of products for the treatment of urological diseases. Sophiris Bio, Inc. (SPHS) Stock | Positive Phase 3 Study ... Learn to Daytrade Breakout Momentum Trading
SPHS | Complete Sophiris Bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.